// App-Quantinova.ai

4739 : The upregulation of cyclooxygenase-2 protein expression by receptor tyrosine kinase inhibitors in bladder cancer in vitro

Researchers

Presenter

  • Jennifer Bourn

Principal Investigators

  • Maria Cekanova

Medical Centers

  • University of Tennessee, Knoxville, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • Platelet-derived growth factor receptor

  • Hepatocyte growth factor receptor

  • Cyclooxygenase-2

  • Epidermal growth factor receptor

  • Kinase Insert Domain Receptor

Drug/Treatment

  • Inlyta

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved